These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30028955)

  • 21. Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer's disease dementia.
    Chiotis K; Saint-Aubert L; Rodriguez-Vieitez E; Leuzy A; Almkvist O; Savitcheva I; Jonasson M; Lubberink M; Wall A; Antoni G; Nordberg A
    Mol Psychiatry; 2018 Jul; 23(7):1666-1673. PubMed ID: 28507319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of (18)FDG PET and (11)C-PIB PET brain imaging on the diagnosis of Alzheimer's disease and other dementias in a regional memory clinic in Hong Kong.
    Shea YF; Ha J; Lee SC; Chu LW
    Hong Kong Med J; 2016 Aug; 22(4):327-33. PubMed ID: 27313272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain FDG PET and the diagnosis of dementia.
    Shivamurthy VK; Tahari AK; Marcus C; Subramaniam RM
    AJR Am J Roentgenol; 2015 Jan; 204(1):W76-85. PubMed ID: 25539279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Role of Single-Subject Brain Metabolic Patterns in the Early Differential Diagnosis of Primary Progressive Aphasias and in Prediction of Progression to Dementia.
    Cerami C; Dodich A; Greco L; Iannaccone S; Magnani G; Marcone A; Pelagallo E; Santangelo R; Cappa SF; Perani D
    J Alzheimers Dis; 2017; 55(1):183-197. PubMed ID: 27662315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Positron emission tomography imaging in dementia.
    Herholz K; Carter SF; Jones M
    Br J Radiol; 2007 Dec; 80 Spec No 2():S160-7. PubMed ID: 18445746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Molecular imaging in neurological diseases].
    Reimold M; la Fougère C
    Radiologe; 2016 Jul; 56(7):580-7. PubMed ID: 27306201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imaging of neurodegenerative cognitive and behavioral disorders: practical considerations for dementia clinical practice.
    Atri A
    Handb Clin Neurol; 2016; 136():971-84. PubMed ID: 27430453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Impact of a Second FDG-PET in Atypical/Unclear Dementia Syndromes.
    Bergeron D; Beauregard JM; Guimond J; Fortin MP; Houde M; Poulin S; Verret L; Bouchard RW; Laforce R
    J Alzheimers Dis; 2016; 49(3):695-705. PubMed ID: 26484904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current Status of
    Sarikaya I; Sarikaya A; Elgazzar AH
    J Nucl Med Technol; 2018 Dec; 46(4):362-367. PubMed ID: 30076253
    [No Abstract]   [Full Text] [Related]  

  • 30. Visual Versus Fully Automated Analyses of 18F-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive Impairment.
    Grimmer T; Wutz C; Alexopoulos P; Drzezga A; Förster S; Förstl H; Goldhardt O; Ortner M; Sorg C; Kurz A
    J Nucl Med; 2016 Feb; 57(2):204-7. PubMed ID: 26585056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FDG-PET and amyloid-PET imaging: the diverging paths.
    Perani D
    Curr Opin Neurol; 2014 Aug; 27(4):405-13. PubMed ID: 24927239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amyloid imaging for differential diagnosis of dementia: incremental value compared to clinical diagnosis and [
    Hellwig S; Frings L; Bormann T; Vach W; Buchert R; Meyer PT
    Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):312-323. PubMed ID: 30094462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brain metabolic maps in Mild Cognitive Impairment predict heterogeneity of progression to dementia.
    Cerami C; Della Rosa PA; Magnani G; Santangelo R; Marcone A; Cappa SF; Perani D
    Neuroimage Clin; 2015; 7():187-94. PubMed ID: 25610780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cross-validation of biomarkers for the early differential diagnosis and prognosis of dementia in a clinical setting.
    Perani D; Cerami C; Caminiti SP; Santangelo R; Coppi E; Ferrari L; Pinto P; Passerini G; Falini A; Iannaccone S; Cappa SF; Comi G; Gianolli L; Magnani G
    Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):499-508. PubMed ID: 26341365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-Alzheimer types of neurodegenerative dementia: clinical and 18F-FDG-PET/CT pictures.
    Grassetto G; Marzola MC; Musto A; Viniamury S; Colletti PM; Perkins AC; Rubello D
    Nucl Med Commun; 2014 Nov; 35(11):1085-92. PubMed ID: 25162962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PET/CT of Dementia.
    Zukotynski K; Kuo PH; Mikulis D; Rosa-Neto P; Strafella AP; Subramaniam RM; Black SE
    AJR Am J Roentgenol; 2018 Aug; 211(2):246-259. PubMed ID: 29949415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brain fluorodeoxyglucose (FDG) PET in dementia.
    Kato T; Inui Y; Nakamura A; Ito K
    Ageing Res Rev; 2016 Sep; 30():73-84. PubMed ID: 26876244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PET/MR in dementia and other neurodegenerative diseases.
    Barthel H; Schroeter ML; Hoffmann KT; Sabri O
    Semin Nucl Med; 2015 May; 45(3):224-33. PubMed ID: 25841277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Technical Considerations on Scanning and Image Analysis for Amyloid PET in Dementia].
    Akamatsu G; Ohnishi A; Aita K; Ikari Y; Yamamoto Y; Senda M
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2017; 73(4):298-308. PubMed ID: 28428473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer's disease.
    Drzezga A; Grimmer T; Henriksen G; Stangier I; Perneczky R; Diehl-Schmid J; Mathis CA; Klunk WE; Price J; DeKosky S; Wester HJ; Schwaiger M; Kurz A
    Neuroimage; 2008 Jan; 39(2):619-33. PubMed ID: 17962045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.